Global Klebsiella Pneumoniae Infection Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Klebsiella Pneumoniae Infection Drug

• 1.1 Definition of Klebsiella Pneumoniae Infection Drug
• 1.2 Klebsiella Pneumoniae Infection Drug Segment by Type
  • 1.2.1 Global Klebsiella Pneumoniae Infection Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 ATI-1503
  • 1.2.3 CA-824
  • 1.2.4 CC-1807
  • 1.2.5 Cefiderocol
  • 1.2.6 Debio-1454
  • 1.2.7 EBX-004
  • 1.2.8 Others
• 1.3 Klebsiella Pneumoniae Infection Drug Segment by Applications
  • 1.3.1 Global Klebsiella Pneumoniae Infection Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Klebsiella Pneumoniae Infection Drug Overall Market
  • 1.4.1 Global Klebsiella Pneumoniae Infection Drug Revenue (2014-2025)
  • 1.4.2 Global Klebsiella Pneumoniae Infection Drug Production (2014-2025)
  • 1.4.3 North America Klebsiella Pneumoniae Infection Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Klebsiella Pneumoniae Infection Drug Status and Prospect (2014-2025)
  • 1.4.5 China Klebsiella Pneumoniae Infection Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Klebsiella Pneumoniae Infection Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Klebsiella Pneumoniae Infection Drug Status and Prospect (2014-2025)
  • 1.4.8 India Klebsiella Pneumoniae Infection Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Klebsiella Pneumoniae Infection Drug
• 2.3 Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug
• 2.4 Industry Chain Structure of Klebsiella Pneumoniae Infection Drug

3 Development and Manufacturing Plants Analysis of Klebsiella Pneumoniae Infection Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Klebsiella Pneumoniae Infection Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Klebsiella Pneumoniae Infection Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Klebsiella Pneumoniae Infection Drug Production and Capacity Analysis
• 4.2 Klebsiella Pneumoniae Infection Drug Revenue Analysis
• 4.3 Klebsiella Pneumoniae Infection Drug Price Analysis
• 4.4 Market Concentration Degree

5 Klebsiella Pneumoniae Infection Drug Regional Market Analysis

• 5.1 Klebsiella Pneumoniae Infection Drug Production by Regions
  • 5.1.1 Global Klebsiella Pneumoniae Infection Drug Production by Regions
  • 5.1.2 Global Klebsiella Pneumoniae Infection Drug Revenue by Regions
• 5.2 Klebsiella Pneumoniae Infection Drug Consumption by Regions
• 5.3 North America Klebsiella Pneumoniae Infection Drug Market Analysis
  • 5.3.1 North America Klebsiella Pneumoniae Infection Drug Production
  • 5.3.2 North America Klebsiella Pneumoniae Infection Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Klebsiella Pneumoniae Infection Drug Import and Export
• 5.4 Europe Klebsiella Pneumoniae Infection Drug Market Analysis
  • 5.4.1 Europe Klebsiella Pneumoniae Infection Drug Production
  • 5.4.2 Europe Klebsiella Pneumoniae Infection Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Klebsiella Pneumoniae Infection Drug Import and Export
• 5.5 China Klebsiella Pneumoniae Infection Drug Market Analysis
  • 5.5.1 China Klebsiella Pneumoniae Infection Drug Production
  • 5.5.2 China Klebsiella Pneumoniae Infection Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Klebsiella Pneumoniae Infection Drug Import and Export
• 5.6 Japan Klebsiella Pneumoniae Infection Drug Market Analysis
  • 5.6.1 Japan Klebsiella Pneumoniae Infection Drug Production
  • 5.6.2 Japan Klebsiella Pneumoniae Infection Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Klebsiella Pneumoniae Infection Drug Import and Export
• 5.7 Southeast Asia Klebsiella Pneumoniae Infection Drug Market Analysis
  • 5.7.1 Southeast Asia Klebsiella Pneumoniae Infection Drug Production
  • 5.7.2 Southeast Asia Klebsiella Pneumoniae Infection Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Klebsiella Pneumoniae Infection Drug Import and Export
• 5.8 India Klebsiella Pneumoniae Infection Drug Market Analysis
  • 5.8.1 India Klebsiella Pneumoniae Infection Drug Production
  • 5.8.2 India Klebsiella Pneumoniae Infection Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Klebsiella Pneumoniae Infection Drug Import and Export

6 Klebsiella Pneumoniae Infection Drug Segment Market Analysis (by Type)

• 6.1 Global Klebsiella Pneumoniae Infection Drug Production by Type
• 6.2 Global Klebsiella Pneumoniae Infection Drug Revenue by Type
• 6.3 Klebsiella Pneumoniae Infection Drug Price by Type

7 Klebsiella Pneumoniae Infection Drug Segment Market Analysis (by Application)

• 7.1 Global Klebsiella Pneumoniae Infection Drug Consumption by Application
• 7.2 Global Klebsiella Pneumoniae Infection Drug Consumption Market Share by Application (2014-2019)

8 Klebsiella Pneumoniae Infection Drug Major Manufacturers Analysis

• 8.1 Acies Bio doo
  • 8.1.1 Acies Bio doo Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
  • 8.1.2 Acies Bio doo Product Introduction, Application and Specification
  • 8.1.3 Acies Bio doo Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Appili Therapeutics
  • 8.2.1 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
  • 8.2.2 Appili Therapeutics Product Introduction, Application and Specification
  • 8.2.3 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Debiopharm International SA
  • 8.3.1 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
  • 8.3.2 Debiopharm International SA Product Introduction, Application and Specification
  • 8.3.3 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Evaxion Biotech ApS
  • 8.4.1 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
  • 8.4.2 Evaxion Biotech ApS Product Introduction, Application and Specification
  • 8.4.3 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 F. Hoffmann-La Roche Ltd
  • 8.5.1 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
  • 8.5.2 F. Hoffmann-La Roche Ltd Product Introduction, Application and Specification
  • 8.5.3 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 FOB Synthesis Inc
  • 8.6.1 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
  • 8.6.2 FOB Synthesis Inc Product Introduction, Application and Specification
  • 8.6.3 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 ImmunoClin Corp
  • 8.7.1 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
  • 8.7.2 ImmunoClin Corp Product Introduction, Application and Specification
  • 8.7.3 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Innovation Pharmaceuticals Inc
  • 8.8.1 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
  • 8.8.2 Innovation Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.8.3 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Kyorin Pharmaceutical Co Ltd
  • 8.9.1 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
  • 8.9.2 Kyorin Pharmaceutical Co Ltd Product Introduction, Application and Specification
  • 8.9.3 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Melinta Therapeutics Inc
  • 8.10.1 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
  • 8.10.2 Melinta Therapeutics Inc Product Introduction, Application and Specification
  • 8.10.3 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Nosopharm SAS
• 8.12 Peptilogics Inc
• 8.13 Pfizer Inc
• 8.14 Phico Therapeutics Ltd
• 8.15 Sarepta Therapeutics Inc
• 8.16 Shionogi & Co Ltd
• 8.17 Syntiron LLC
• 8.18 Tetraphase Pharmaceuticals Inc

9 Development Trend of Analysis of Klebsiella Pneumoniae Infection Drug Market

• 9.1 Global Klebsiella Pneumoniae Infection Drug Market Trend Analysis
  • 9.1.1 Global Klebsiella Pneumoniae Infection Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Klebsiella Pneumoniae Infection Drug Regional Market Trend
  • 9.2.1 North America Klebsiella Pneumoniae Infection Drug Forecast 2019-2025
  • 9.2.2 Europe Klebsiella Pneumoniae Infection Drug Forecast 2019-2025
  • 9.2.3 China Klebsiella Pneumoniae Infection Drug Forecast 2019-2025
  • 9.2.4 Japan Klebsiella Pneumoniae Infection Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Klebsiella Pneumoniae Infection Drug Forecast 2019-2025
  • 9.2.6 India Klebsiella Pneumoniae Infection Drug Forecast 2019-2025
• 9.3 Klebsiella Pneumoniae Infection Drug Market Trend (Product Type)
• 9.4 Klebsiella Pneumoniae Infection Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Klebsiella Pneumoniae Infection Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List